| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| Radiation Therapy Services, Inc. |
| 1850 Boy Scout Drive, Suite A-101, Fort Myers, FL 33907 * (941) 931-7275 |
| The company is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, from conventional to advanced treatments. |
| Manager | Tier | Phone |
| Robert W. Baird & Company | Lead Manager | (414) 765-3632 |
| Wheat First Union | Co-manager |
| NASNTL: | RTSI | Service: | SIC 8011 | |
| Type of Shares: | Common Shares | Filing Date: | 9/25/98 | |
| U.S. Shares Filed: | 0 | Filing Price: | - | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $36,000,000 | |
| Primary Shares: | 0 | Expenses: | - | |
| Secondary Shares: | 0 | Post-IPO Shares: | ||
| Employees: | 317 |
| Issuer's Law Firm: | Taft, Stettinius & Hollister |
| Bank's Law Firm: | Shumaker, Loop & Kendrick, LLP |
| Auditor: | Pricewaterhouse Coopers LLC |
Dollar amounts in U.S. millions except for per share data | |||||
| 6 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 12/31/97 | 6/30/98 | 6/30/97 | 6/30/98 | ||
| Revenue: | $29.35 | $21.08 | $12.45 | Assets: | $59.24 |
| Net Income: | $2.14 | $1.73 | $1.32 | Curr Assets: | $11.73 |
| EPS: | Liabilities: | $41.01 | |||
| Prior EPS: | Curr Liab: | $18.03 | |||
| Cash Flow/Oper: | $5.33 | $3.30 | $1.66 | Equity: | $18.23 |
| Cash Flow/Fin: | -$2.15 | -$2.44 | -$0.57 | Cash: | $0.94 |
| Cash Flow/Inv: | -$2.23 | -$1.06 | -$0.32 | Working Cap: | -$6.30 |
| Competition |
| The Company's business is highly competitive. The principal competitive factors are patient service and satisfaction, pricing, quality of care, radiation oncologists' experience and expertise, strength of operational systems, access to advanced treatment procedures, technologically advanced equipment, management information systems, managed care expertise, patient referrals and access, management strength, regional network area coverage and quality assurance programs. The Company's centers face competition from several sources, including sole practitioners, single and multiple specialty physician groups, physician practice management companies, hospitals and operators of other radiation therapy centers. The Company may have to compete against these entities for patient referrals, contracts with payors and/or acquisitions. Increased competition could have a material adverse effect on the Company's financial condition and results of operations. The Company's success is significantly dependent on the ability of its radiation oncologists to attract patient referrals from third parties. A substantial portion of these referrals are made by physicians who have no contractual obligation to refer patients to the Company's radiation oncologists. The inability of the Company's physicians to attract sufficient referrals or the loss of a significant number of referring physicians could have a material adverse effect on the Company's financial condition and operating results. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to provide certain indebtedness of the company and to finance certain distributions to existing shareholders in connection with the termination of the company's S Corporation status. |